Delaware
(State or other jurisdiction
of incorporation or organization)
|
87-0565309
(I.R.S. Employer
Identification No.)
|
Roger Bivans
Baker & McKenzie LLP
1900 North Pearl
Suite 1500
Dallas, TX 75201
(214) 978-3095
|
Chayce D. Clark
Executive Vice President and General Counsel
Nu Skin Enterprises, Inc.
75 West Center Street
Provo, Utah 84601
(801) 345-1000
|
Large accelerated filer ☑
|
Accelerated filer ☐
|
Non-accelerated filer ☐
|
Smaller reporting company ☐
|
Emerging growth company ☐
|
Item 3. |
Incorporation of Documents by Reference.
|
(a)
|
the Company’s Annual Report on Form 10‑K for the fiscal year ended December 31, 2023;
|
(b)
|
the Company’s Quarterly Report on Form 10‑Q for the quarter ended March 31, 2024;
|
(c)
|
the Company’s Current Reports on Form 8-K filed on February 6, 2024, February 14, 2024, March 18,
2024 and June 6, 2024; and
|
(d)
|
the description of the Company’s Class A Common Stock, par value $0.001 per share, filed as Exhibit 4.2 to the Company’s Annual Report
on Form 10-K for the fiscal year ended December 31, 2023, filed on February 15, 2024, together with any amendment or report filed with the Commission for the purpose of updating such description.
|
Item 4. |
Description of Securities.
|
Item 5. |
Interests of Named Experts and Counsel.
|
Item 6. |
Indemnification of Directors and Officers.
|
Item 7.
|
Exemption from Registration Claimed.
|
Item 8.
|
Exhibits.
|
Exhibit
Number |
Description
|
4.1
|
|
4.2
|
|
4.3
|
|
4.4
|
|
4.5
|
|
5.1*
|
|
23.1*
|
|
23.2*
|
|
24.1*
|
|
99.1
|
|
107.1*
|
Item 9. |
Undertakings.
|
NU SKIN ENTERPRISES, INC.
|
|||
By |
/s/ Ryan S. Napierski
|
||
Name: Ryan S. Napierski
|
|||
Title: President and Chief Executive Officer
|
Signature
|
Title
|
Date
|
||
/s/ Steven J. Lund
|
Executive Chairman of the Board
|
June 7, 2024
|
||
Steven J. Lund
|
||||
/s/ Ryan S. Napierski
|
President, Chief Executive Officer and Director
|
June 7, 2024
|
||
Ryan S. Napierski
|
(Principal Executive Officer)
|
|||
/s/ James D. Thomas
|
Chief Financial Officer
|
June 7, 2024
|
||
James D. Thomas
|
(Principal Financial Officer and Accounting Officer)
|
|||
/s/ Emma S. Battle
|
Director
|
June 7, 2024
|
||
Emma S. Battle
|
||||
/s/ Daniel W. Campbell
|
Director
|
June 7, 2024
|
||
Daniel W. Campbell
|
||||
/s/ Laura Nathanson
|
Director
|
June 7, 2024
|
||
Laura Nathanson
|
||||
/s/ Thomas R. Pisano
|
Director
|
June 7, 2024
|
||
Thomas R. Pisano
|
||||
/s/ Zheqing Shen
|
Director
|
June 7, 2024
|
||
Zheqing Shen
|
||||
/s/ Edwina D. Woodbury
|
Director
|
June 7, 2024
|
||
Edwina D. Woodbury
|
Baker & McKenzie LLP
1900 North Pearl Street
Suite 1500 Dallas, TX 75201 United States Tel: +1 214 978 3000
Fax: +1 214 978 3099
www.bakermckenzie.com
|
Asia Pacific
Bangkok
Beijing
Brisbane
Hanoi
Ho Chi Minh City
Hong Kong
Jakarta
Kuala Lumpur*
Manila*
Melbourne
Seoul
Shanghai
Singapore
Sydney
Taipei
Tokyo
Yangon
Europe, Middle East
& Africa Abu Dhabi
Almaty
Amsterdam
Antwerp
Bahrain
Barcelona
Berlin
Brussels
Budapest
Cairo
Casablanca
Doha
Dubai
Dusseldorf
Frankfurt/Main
Geneva
Istanbul
Jeddah*
Johannesburg
Kyiv
London
Luxembourg
Madrid
Milan
Munich
Paris
Prague
Riyadh*
Rome
Stockholm
Vienna
Warsaw
Zurich
The Americas
Bogota
Brasilia**
Buenos Aires
Caracas
Chicago
Dallas
Guadalajara
Houston
Juarez
Lima
Los Angeles
Mexico City
Miami
Monterrey
New York
Palo Alto
Porto Alegre**
Rio de Janeiro**
San Francisco
Santiago
Sao Paulo**
Tijuana
Toronto
Washington, DC
* Associated Firm
** In cooperation with Trench, Rossi e Watanabe Advogados
|
June 07, 2024
Nu Skin Enterprises, Inc.
75 West Center Street
Provo, Utah 84601
Re: Nu Skin Enterprises, Inc. Registration Statement on Form S-8
We have acted as special counsel for Nu Skin Enterprises, Inc., a Delaware corporation (the “Company”), in connection with its filing with the Securities and Exchange Commission (the
“SEC”) of a registration statement on Form S-8 filed on the date hereof (the “Registration Statement”) under the Securities Act of 1933, as amended (the “Securities Act”), with respect to the registration of 1,219,919 shares of the Company’s Class A Common Stock, par value $0.001 per share (the “Shares”) pursuant to the Company’s 2024 Omnibus Incentive Plan (the “Plan”).
We have examined originals or copies certified or otherwise identified to our satisfaction of (i) the Registration Statement, (ii) the Amended and Restated Certificate of Incorporation
of the Company, as amended and supplemented to date, (iii) the Fifth Amended and Restated Bylaws of the Company, as amended to date, (iv) the corporate proceedings with respect to the filing of the Registration Statement, (v) the
corporate proceedings taken with respect to the sale and issuance of the Shares under the Plan, and (vi) such other corporate records, agreements, documents and instruments and certificates or comparable documents of public officials
and officers and representatives of the Company as we have deemed necessary or appropriate for the expression of the opinions contained herein. In such examination, we have assumed the genuineness of all signatures, the authenticity of
all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as photostatic or certified copies and the authenticity of the originals of such copies.
Based upon and subject to the foregoing, and subject to the additional assumptions and qualifications set forth below, we are of the opinion that the Shares have been duly authorized
and, when and to the extent issued, delivered and paid for in accordance with the Plan, the Shares will be validly issued, fully paid and non-assessable.
The opinion expressed above is limited to the General Corporation Law of the State of Delaware and the federal securities laws of the United States of America.
This opinion letter is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated. We hereby consent to the use of our opinion
as herein set forth as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the prospectus forming a part of the Registration Statement. In giving this consent, we do not hereby admit
that we come within the category of
|
persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the SEC promulgated thereunder or Item 509 of Regulation S-K.
|
|
/s/ Baker & McKenzie LLP | |
BAKER & MCKENZIE LLP |
Security
Type
|
Security Class Title
|
Fee
Calculation
Rule
|
Amount
Registered(1)
|
Proposed
Maximum
Offering
Price Per
Unit(2)
|
Maximum
Aggregate
Offering Price(2)
|
Fee Rate
|
Amount of
Registration Fee
|
|||||||||||||||
Equity
|
Class A Common Stock, par value $.001 per share
|
Other
|
1,219,919
|
$
|
13.34
|
$
|
16,273,719.46
|
0.00014760
|
$
|
2,402.00
|
||||||||||||
Total Offering Amounts
|
$
|
16,273,719.46
|
$
|
2,402.00
|
||||||||||||||||||
Total Fee Offsets
|
$
|
—
|
||||||||||||||||||||
Net Fee Due
|
$
|
2,402.00
|
(1) |
Pursuant to Rule 416(a) under the Securities Act of 1933 (the “Securities Act”), this Registration Statement on Form S-8 also relates to such additional number of shares of the Company’s Class A Common Stock available for issuance under
the Company’s 2024 Omnibus Incentive Plan (the “Plan”) as may be required pursuant to the plan in the event of a stock dividend, stock split, recapitalization or other similar event or transaction, or as otherwise provided for in the Plan.
|
(2) |
Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) and (h) under the Securities Act, on the basis of the average of the high and low prices per share of the Company’s Class A Common Stock
as reported on the New York Stock Exchange on May 31, 2024.
|